Skip to main content

Table 3 Changes of cytokines before and after treatments

From: A comparative analysis of platelet-rich plasma alone versus combined with extracorporeal shockwave therapy in athletes with patellar tendinopathy and knee pain: a randomized controlled trial

 

PS (PRP + SHAM)

PE (PRP + ESWT)

p-value*

IL-33

 Before treatment

1.44 ± 0.5

0.69 ± 0.24

> 0.05

 After treatment

4.61 ± 1.67

1.70 ± 0.68

> 0.05

 p-value#

 > 0.05

 > 0.05

 

IL-17

 Before treatment

0.06 ± 0.02

0.09 ± 0.02

> 0.05

 After treatment

0.15 ± 0.04

0.14 ± 0.03

> 0.05

 p-value

< 0.05

< 0.05

 

IL-6

 Before treatment

1.15 ± 0.13

1.71 ± 0.39

> 0.05

 After treatment

1.97 ± 0.34

1.32 ± 0.25

0.031

 p-value

< 0.05

> 0.05

 

IL-15

 Before treatment

19.07 ± 7.32

7.70 ± 1.41

> 0.05

 After treatment

19.22 ± 6.02

11.15 ± 1.47

> 0.05

 p-value

> 0.05

< 0.05

 

VEGF-A

 Before treatment

244.70 ± 45.47

218.00 ± 33.74

> 0.05

 After treatment

220.55 ± 44.54

226.04 ± 34.97

> 0.05

 p-value

< 0.05

> 0.05

 
  1. *The p-values less than 0.05 are accepted as statistically significant as compared between the PS and PE groups
  2. #The p-values less than 0.05 were accepted as statistically significant as compared with the data before treatment (Pre)